Company Overview of bioCSL Inc.
bioCSL Inc. manufactures and supplies flu vaccines. The company offers AFLURIA, an inactivated influenza vaccine indicated for active immunization against influenza disease caused by influenza virus subtypes A and type B present in the vaccine. It provides flu vaccine to Australia, New Zealand, and various countries in Europe, South America, and Asia. The company’s products are available through a network of distributors. bioCSL Inc. was formerly known as CSL Biotherapies, Inc. and changed its name to bioCSL Inc. The company was founded in 1968 and is based in King of Prussia, Pennsylvania. bioCSL Inc. operates as a subsidiary of CSL Ltd.
1020 First Avenue
King of Prussia, PA 19406
Founded in 1968
Key Executives for bioCSL Inc.
bioCSL Inc. Key Developments
Similar Private Companies By Industry
|Acylin Therapeutics, Inc.||United States|
|Warner Chilcott Company, Inc.||United States|
|Adheron Therapeutics, Inc.||United States|
|Xellia Pharmaceuticals, Inc.||United States|
|Pathogenics, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact bioCSL Inc., please visit www.cslbiotherapies-us.com. Company data is provided by Capital IQ. Please use this form to report any data issues.